EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, PHRRF: Pharmather Hldgs Ltd

17 Oct 2025
LAST:

0.0932

CHANGE:
 0.00		OPEN:
0.1130		HIGH:
0.1130		ASK:
0.0000		VOLUME:
1.56M
CHG(%):
4.21		PREV:
0.0973		LOW:
0.0865		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
17 Oct 250.11300.11300.08650.09321.56M
16 Oct 250.11180.11550.08500.09731.25M
15 Oct 250.11010.12400.10580.1060358.4K
14 Oct 250.11030.12500.10000.1125503.1K
13 Oct 250.12210.13670.11110.1282132.5K
10 Oct 250.11000.11610.09500.11401.23M
09 Oct 250.12000.12490.10310.1076734.1K
08 Oct 250.14000.14000.11720.1178894.2K
07 Oct 250.11610.13770.11610.1300621.6K
06 Oct 250.15710.15890.12510.1353601.7K

COMPANY PROFILE

Name:Pharmather Hldgs Ltd
About:PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia, procedural sedation as well as depression, surgical and pain management. It develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX wearable pump for the maintenance of general anesthesia for diagnostic, surgical procedures and pain indications. In addition, the company offers PHARMAPATCH, a microneedle patch technology solution, which includes hydrogel-forming and gelatin methacryloyl delivery system for the treatment of psychedelics and infectious diseases. Further, it has license agreement with BioRAE, Inc. for the development and commercialization of a novel biocompatible and biodegradable gelatin methacryloyl microneedle; and the University of Kansas to develop and commercialize the intellectual property of ketamine to treat ALS; with the University of Arizona for the development and commercialization of ketamine in the treatment of Parkinson's disease; as well as holds a patent and know-how license agreement with The Queen's University of Belfast to develop and commercialize hydrogel-forming microneedle patch delivery technology. The company was incorporated in 2019 and is headquartered in Toronto, Canada.
Sector:Healthcare
Industry:Biotechnology
Address:82 Richmond Street East, Toronto, ON, Canada, M5C 1P1
Website:https://www.pharmather.com
CIK:0001886748
ISIN:CA71716H1082
FIGI:BBG00Y7BJQ32

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.1115.2%
MA10:0.1122.5%
MA20:0.1785.2%
MA50:0.24157.3%
MA100:0.26180.2%
MA200:0.20119.7%
RSI14:15.91 
WPR14:-100.00 
MTM14:-0.17
ROC14:-0.65 
ATR:0.04 
Week High:0.1446.7%
Week Low:0.099.6%
Month High:0.30221.9%
Month Low:0.09119.7%
Year High:0.55490.1%
Year Low:0.099.6%
Volatility:166.67